Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery
Status:
Completed
Trial end date:
2012-04-16
Target enrollment:
Participant gender:
Summary
The study will investigate the efficacy of various doses and regimens of EXC 001 in reducing
skin scarring in subjects undergoing revision of scars from prior surgery. The study will
also evaluate the safety and tolerability of EXC 001 and placebo.